Op-Ed: Mark Cuban won’t fix our drug pricing problem
2 years, 5 months ago

Op-Ed: Mark Cuban won’t fix our drug pricing problem

LA Times  

Mark Cuban, the billionaire “Shark Tank” celebrity and Dallas Mavericks owner, is getting attention again — this time for his Mark Cuban Cost Plus Drug Co., which seeks to reduce prescription drug prices for Americans. These monopolies reflect intentional and longstanding government policies to incentivize research investments by rewarding drug developers with substantial profits for new drugs that improve health and extend lives. Formal cost-effectiveness analysis compares a drug’s cost — accounting for savings the drug can create elsewhere, such as by reducing expensive hospitalizations — to its benefits, including extended life expectancy and improved quality of life. Efforts such as the Mark Cuban Cost Plus Drug Co. can help bring cost relief to many Americans for generic medications they rely on.

History of this topic

Mark Cuban’s War on Drug Prices: ‘How Much Fucking Money Do I Need?’
54 years, 11 months ago
Out of Mavericks spotlight, Mark Cuban now aiming at ‘f—ing up’ pharmacy industry
6 months, 1 week ago
Want to pitch your business idea to billionaire Mark Cuban? Email him!
8 months ago
Bayer makes a deal on popular contraceptive with Mark Cuban's online pharmacy
10 months ago
10 drugs targeted for Medicare price negotiations as Biden pitches cost reductions
1 year, 3 months ago
Biden says he’s focused ‘intensely’ on lowering drug costs
1 year, 9 months ago
Mark Cuban has been taking on the drug industry. But which one?
1 year, 10 months ago
Can billionaire celebrity Mark Cuban fix America’s broken health system?
2 years, 6 months ago
Trump plan to curb drug costs dealt setback in court
4 years ago

Discover Related